Novartis
NVS
#57
Rank
HK$1.960 T
Marketcap
HK$1,022
Share price
0.89%
Change (1 day)
34.00%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Market capitalization of Novartis (NVS)

Market cap: HK$1.960 Trillion

As of December 2025 Novartis has a market cap of HK$1.960 Trillion. This makes Novartis the world's 57th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novartis from 1998 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$1.960 T28.41%
2024HK$1.527 T-5.78%
2023HK$1.620 T6.31%
2022HK$1.524 T-0.48%
2021HK$1.531 T-9.25%
2020HK$1.688 T0.9%
2019HK$1.673 T8.3%
2018HK$1.544 T0.28%
2017HK$1.540 T14.85%
2016HK$1.341 T-16.98%
2015HK$1.615 T-7.01%
2014HK$1.737 T15.12%
2013HK$1.509 T27.83%
2012HK$1.180 T10.09%
2011HK$1.072 T2.4%
2010HK$1.047 T8.03%
2009HK$969.47 B11.32%
2008HK$870.86 B-9.18%
2007HK$958.89 B-8.59%
2006HK$1.049 T10.37%
2005HK$950.46 B-0.28%
2004HK$953.14 B8.58%
2003HK$877.79 B23.82%
2002HK$708.92 B-2.25%
2001HK$725.24 B-20.28%
2000HK$909.78 B21.82%
1999HK$746.82 B-28.18%
1998HK$1.039 T

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Novartis was reported to be:

HK$2.000 Trillion
by Nasdaq info icon info icon
HK$1.943 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
HK$1.888 T-3.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.122 T-42.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.752 T 91.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$912.44 B-53.47%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$745.95 B-61.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$255.83 B-86.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
HK$805.50 B-58.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.641 T-16.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.176 T 11.00%๐Ÿ‡ฌ๐Ÿ‡ง UK